Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Fletcher

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 27, 2021
Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically, and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy TrialsKaatje Bollaerts, Mark A Fletcher, Jose A Suaya, et al.
Frontiers in Public Health|July 25, 2024
Serotype distribution of invasive pneumococcal disease from countries of the WHO Africa, Americas, Eastern Mediterranean, South-East Asia, and Western Pacific regions: a systematic literature review from 2010 to 2021Mark A Fletcher, Derek Daigle, Mariana Siapka, et al.
Vaccine|December 1, 2019
Letter to the editorAdriano Arguedas, Bradford D Gessner, Scott Williams, et al.
Neuropsychologia|December 13, 2016
Hippocampal structure predicts cortical indices of reactivation of related itemsJohn A Walker, Kathy A Low, Mark A Fletcher, et al.
Vaccine|September 2, 2025
Recommendations for pneumococcal vaccination of at-risk children: a global overview (2022-2024)Derek Daigle, Graciela Morales, Kyla Hayford, et al.
IJID Regions|August 18, 2025
Cost-effectiveness of a 13-valent pneumococcal conjugate vaccine compared with currently available pneumococcal conjugate vaccines in Indian childrenSantosh Ramesh Taur, Ritika Rampal, Sripriya Sathyanarayanan, et al.
Expert Review of Vaccines|September 16, 2024
Adult indication 13-valent pneumococcal conjugate vaccine clinical development overview: formulation, safety, immunogenicity (dosing and sequence), coadministration, and efficacyMark A Fletcher, Beate Schmoele-Thoma, Jelena Vojicic, et al.
Vaccine|September 30, 2024
National recommendations for adult pneumococcal vaccination in countries of the WHO regions of Americas, Africa, Eastern Mediterranean, South East Asia, and Western PacificMark A Fletcher, Jelena Vojicic, Derek Daigle, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|August 11, 2025
Lyme Borreliosis and Tick Surveillance Epidemiology in the WHO Regions of the Americas, Eastern Mediterranean, Europe, South-East Asia, and Western Pacific: A Systematic Literature Review (2005-2022) Beyond North America (Canada, United States of America), European Union Countries, and ChinaLeah Burn, Mark A Fletcher, Jehidys Montiel, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 27, 2021
Letter to the editor regarding "Budget impact analysis of pneumococcal conjugate vaccines in Colombia"Juan M Reyes, Jorge LaRotta, Natalia Castano, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 27, 2021
Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically, and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy TrialsKaatje Bollaerts, Mark A Fletcher, Jose A Suaya, et al.
Frontiers in Public Health|July 25, 2024
Serotype distribution of invasive pneumococcal disease from countries of the WHO Africa, Americas, Eastern Mediterranean, South-East Asia, and Western Pacific regions: a systematic literature review from 2010 to 2021Mark A Fletcher, Derek Daigle, Mariana Siapka, et al.
Vaccine|December 1, 2019
Letter to the editorAdriano Arguedas, Bradford D Gessner, Scott Williams, et al.
Neuropsychologia|December 13, 2016
Hippocampal structure predicts cortical indices of reactivation of related itemsJohn A Walker, Kathy A Low, Mark A Fletcher, et al.
Vaccine|September 2, 2025
Recommendations for pneumococcal vaccination of at-risk children: a global overview (2022-2024)Derek Daigle, Graciela Morales, Kyla Hayford, et al.
IJID Regions|August 18, 2025
Cost-effectiveness of a 13-valent pneumococcal conjugate vaccine compared with currently available pneumococcal conjugate vaccines in Indian childrenSantosh Ramesh Taur, Ritika Rampal, Sripriya Sathyanarayanan, et al.
Expert Review of Vaccines|September 16, 2024
Adult indication 13-valent pneumococcal conjugate vaccine clinical development overview: formulation, safety, immunogenicity (dosing and sequence), coadministration, and efficacyMark A Fletcher, Beate Schmoele-Thoma, Jelena Vojicic, et al.
Vaccine|September 30, 2024
National recommendations for adult pneumococcal vaccination in countries of the WHO regions of Americas, Africa, Eastern Mediterranean, South East Asia, and Western PacificMark A Fletcher, Jelena Vojicic, Derek Daigle, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|August 11, 2025
Lyme Borreliosis and Tick Surveillance Epidemiology in the WHO Regions of the Americas, Eastern Mediterranean, Europe, South-East Asia, and Western Pacific: A Systematic Literature Review (2005-2022) Beyond North America (Canada, United States of America), European Union Countries, and ChinaLeah Burn, Mark A Fletcher, Jehidys Montiel, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 27, 2021
Letter to the editor regarding "Budget impact analysis of pneumococcal conjugate vaccines in Colombia"Juan M Reyes, Jorge LaRotta, Natalia Castano, et al.
Pageof 6